Junior Miner Looking Good for Commercial Production in 2018, Analysts Say

  ()
A flagship Nevada project is showing results and the company anticipates commencing commercial production in the first quarter of 2018. read more >

Guyana Shield Is Host to Multiple Gold Deposits

  ()
As two Guyana projects begin commercial gold production, a new mineral resource estimate is in the works for a third project. read more >

Gold Major to Increase Dividend by 50% in 2018

Research Report
  ()
BMO Capital Markets reported on this miner's outlook for 2018 and beyond. read more >

Keith Barron Wants to Mine U3O8 'Cheep'

Contributed Opinion
  ()
More mining companies should follow the example of the garimpeiro miners of Brazil who mine until they fail to make a profit, says Bob Moriarty of 321 Gold, who discusses one gold and one uranium company that may be changing the paradigm. read more >

Cryptojunkies: Beware the Ides of December

Contributed Opinion
  ()
As Bitcoin futures are set to begin trading next week, precious metals expert Michael Ballanger discusses movements in gold and cryptocurrencies. read more >

Jack Chan's Weekly Precious Metals Market Update

Contributed Opinion
  ()
Technical analyst Jack Chan charts the latest movements in the gold and silver markets. read more >

Positive Drill Results Confirm Large-Scale Potential for Nevada Lithium Project

Contributed Opinion
  ()
Drill results from a Nevada lithium project caught the attention of The Critical Investor. read more >
Expert Investing Ideas

"RXII's sd-rxRNA can augment already amazing results in immunotherapy."

–John Vandermosten, Zacks Small-Cap Research


"WPM is trading consistently cheaper than its 'peers' and the miners."

–Charles Gibson, Edison Investment Research


"RPM documented thick sulphide mineralization at Florida Canyon."

–Michael Gray, Macquarie Capital Markets


"We still believe GSV is undervalued."

–Joe Reagor, ROTH Capital Partners


Get Our Streetwise Reports Newsletter Free

A valid email address is required to subscribe

Zinc Explorer Finally Hits at Zone 3; How Big Can the Resource Get?

Contributed Opinion
  ()
The Critical Investor provides an update on this zinc explorer's latest drill results. read more >

A New Breed of Regenerative Therapy Companies Taking Hold

Contributed Opinion
  ()
A regenerative therapy company with expertise in both cell therapy development and manufacturing, and a potential treatment for diabetes, differentiates this company, says Hunter Diamond, CFA, CEO of Diamond Equity Research. read more >

Shining a Light on an Out-of-Favor Oil Stock

Contributed Opinion
  ()
Technical analyst Clive Maund charts an oil and gas explorer that he believes is under the radar of most investors. read more >

Biotech Delivers 'Great' Phase 2 Data in NASH

Contributed Opinion
  ()
John McCamant of the Medical Technology Stock Letter raised his target price on this company given the earning potential of a once-a-day oral treatment for liver disease in what could be a $35 billion market. read more >